Immunic
IMUX
IMUX
61 hedge funds and large institutions have $75.7M invested in Immunic in 2024 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 18 increasing their positions, 8 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
22% more funds holding
Funds holding: 50 → 61 (+11)
84% less call options, than puts
Call options by funds: $67K | Put options by funds: $418K
Holders
61
Holding in Top 10
1
Calls
$67K
Puts
$418K
Top Buyers
| 1 | +$11.8M | |
| 2 | +$11.8M | |
| 3 | +$9.27M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$9.23M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$7.38M |
Top Sellers
| 1 | -$571K | |
| 2 | -$493K | |
| 3 | -$487K | |
| 4 |
CAC
Cowen and Company
New York
|
-$476K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$421K |